Practical guidelines for using PRP in the orthopaedic office

By Santos F. Martinez, MD

The use of biologics such as platelet-rich plasma (PRP), mesenchymal stem cells, or growth factors in the orthopaedic office setting is becoming more common, fueled, in part, by a growing body of research and increasing market demand for alternative methods of nonsurgical management of soft-tissue and musculoskeletal conditions.

The use of biologics has been facilitated by advances in imaging technology such as musculoskeletal ultrasound. In addition, platelet processing centrifuges are becoming more affordable. Practical strategies for office use depend on the surgeon’s patient flow and practice patterns.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!